| Typicality: | 0.274 |
| Saliency: | 0.058 |
| to erlotinib | 4 | location |
| to inis | 2 | location |
| mutation → be associated with → primary resistance | 4 |
| negative | neutral | positive |
| 0.246 | 0.698 | 0.056 |
| Raw frequency | 4 |
| Normalized frequency | 0.058 |
| Modifier score | 0.500 |
| Perplexity | 388.130 |